Level Four Advisory Services, LLC Novartis Ag Transaction History

Level Four Advisory Services, LLC

  • $2.29 Billion
  • Q4 2024

A detailed history of Level Four Advisory Services, LLC transactions in Novartis Ag stock. As of the latest transaction made, Level Four Advisory Services, LLC holds 9,931 shares of NVS stock, worth $1.11 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
9,931
Previous 9,979 0.48%
Holding current value
$1.11 Million
Previous $1.15 Million 15.78%
% of portfolio
0.04%
Previous 0.05%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$96.78 - $117.18 $4,645 - $5,624
-48 Reduced 0.48%
9,931 $966,000
Q3 2024

Nov 14, 2024
SELL
$106.13 - $120.89 $90,210 - $102,756
-850 Reduced 7.85%
9,979 $1.15 Million
Q2 2024

Aug 09, 2024
SELL
$92.57 - $107.37 $69,797 - $80,956
-754 Reduced 6.51%
10,829 $1.15 Million
Q1 2024

May 13, 2024
BUY
$95.27 - $108.47 $18,291 - $20,826
192 Added 1.69%
11,583 $1.12 Million
Q4 2023

Feb 08, 2024
SELL
$92.27 - $101.54 $65,419 - $71,991
-709 Reduced 5.86%
11,391 $1.15 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $78,246 - $86,837
-826 Reduced 6.39%
12,100 $1.23 Million
Q2 2023

Jul 10, 2023
BUY
$92.52 - $104.91 $170,051 - $192,824
1,838 Added 16.58%
12,926 $1.3 Million
Q1 2023

Jun 05, 2023
BUY
$80.03 - $92.81 $175,825 - $203,903
2,197 Added 24.71%
11,088 $1.02 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $203,985 - $249,804
-2,700 Reduced 23.29%
8,891 $806,000
Q3 2022

Nov 07, 2022
SELL
$74.61 - $87.26 $33,425 - $39,092
-448 Reduced 3.72%
11,591 $881,000
Q2 2022

Aug 08, 2022
SELL
$80.52 - $93.75 $122,873 - $143,062
-1,526 Reduced 11.25%
12,039 $1.02 Million
Q1 2022

May 10, 2022
BUY
$80.11 - $90.62 $408,801 - $462,433
5,103 Added 60.3%
13,565 $1.19 Million
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $201,083 - $222,351
-2,523 Reduced 22.97%
8,462 $740,000
Q3 2021

Oct 12, 2021
BUY
$81.78 - $95.14 $644,589 - $749,893
7,882 Added 254.01%
10,985 $898,000
Q2 2021

Aug 09, 2021
BUY
$85.24 - $94.15 $6,137 - $6,778
72 Added 2.38%
3,103 $283,000
Q1 2021

May 10, 2021
SELL
$83.5 - $98.47 $37,575 - $44,311
-450 Reduced 12.93%
3,031 $259,000
Q4 2020

Feb 10, 2021
SELL
$78.07 - $94.43 $8,431 - $10,198
-108 Reduced 3.01%
3,481 $329,000
Q3 2020

Nov 02, 2020
SELL
$82.14 - $91.0 $63,740 - $70,616
-776 Reduced 17.78%
3,589 $312,000
Q2 2020

Aug 17, 2020
BUY
$80.93 - $91.1 $353,259 - $397,651
4,365 New
4,365 $380,000
Q2 2020

Jul 27, 2020
SELL
$80.93 - $91.1 $329,223 - $370,594
-4,068 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$70.67 - $99.01 $12,225 - $17,128
173 Added 4.44%
4,068 $332,000
Q4 2019

Feb 13, 2020
BUY
$84.35 - $95.37 $22,943 - $25,940
272 Added 7.51%
3,895 $392,000
Q3 2019

Nov 12, 2019
SELL
$85.54 - $94.26 $9,751 - $10,745
-114 Reduced 3.05%
3,623 $315,000
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $15,155 - $18,652
201 Added 5.68%
3,737 $341,000
Q1 2019

May 15, 2019
SELL
$75.32 - $86.15 $11,674 - $13,353
-155 Reduced 4.2%
3,536 $340,000
Q4 2018

Feb 08, 2019
BUY
$73.66 - $82.02 $64,452 - $71,767
875 Added 31.07%
3,691 $317,000
Q3 2018

Nov 14, 2018
SELL
$66.94 - $77.43 $20,751 - $24,003
-310 Reduced 9.92%
2,816 $243,000
Q2 2018

Aug 14, 2018
SELL
$64.91 - $73.36 $5,257 - $5,942
-81 Reduced 2.53%
3,126 $236,000
Q1 2018

May 14, 2018
SELL
$70.39 - $84.15 $22,032 - $26,338
-313 Reduced 8.89%
3,207 $259,000
Q4 2017

Feb 13, 2018
SELL
$72.33 - $77.64 $1.03 Million - $1.11 Million
-14,250 Reduced 80.19%
3,520 $296,000
Q3 2017

Apr 03, 2018
SELL
$74.14 - $77.27 $3,113 - $3,245
-42 Reduced 0.24%
17,770 $1.53 Million
Q3 2017

Nov 15, 2017
BUY
$74.14 - $77.27 $805,975 - $840,002
10,871 Added 156.62%
17,812 $1.53 Million
Q2 2017

Sep 20, 2017
SELL
N/A
-3,542 Reduced 33.79%
6,941 $512,000
Q1 2017

Sep 20, 2017
BUY
N/A
10,483
10,483 $775,000

Others Institutions Holding NVS

# of Institutions
1,478
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $241B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Level Four Advisory Services, LLC Portfolio

Follow Level Four Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Level Four Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email